NCT05434299View on ClinicalTrials.gov

A Study of TFX05-01 in Patients With Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 5, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Advanced Solid Tumor
Interventions
DRUG

TFX05-01

TFX05-01 for intravenous

Trial Locations (4)

Unknown

RECRUITING

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

The 1st Affiliated Hospital of Henan University of Science and Technology, Luoyang

RECRUITING

Henan Cancer Hospital, Zhengzhou

All Listed Sponsors
lead

Shenzhen Yangli Pharmaceutical Technology Co., Ltd

INDUSTRY